Back
Orchestra BioMed Holdings Vs. Janux Therapeutics Industry Stock Comparison
Sell
27
OBIO
Orchestra BioMed Holdings
Last Price:
$5.39
Seasonality Move:
7.97%
Sell
23
JANX
Janux Therapeutics
Last Price:
$50.53
Seasonality Move:
80.32%
Sell
27
Orchestra BioMed Holdings (OBIO)
is a Sell
Is Orchestra BioMed Holdings a Buy, Sell or Hold?
-
The current Orchestra BioMed Holdings [OBIO] share price is $5.37. The Score for OBIO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
OBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
-
The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OBIO Stock Price Chart
What is Orchestra BioMed Holdings's stock price today?
-
The Orchestra BioMed Holdings share price today is $5.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OBIO is experiencing selling pressure, which indicates risk of future bearish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $50.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
OBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 52.95 | Buy |
Chaikin Money Flow: | -52327 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.62 - 5.54) | Buy |
Bollinger Bands (100): | (4.91 - 6.05) | Sell |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 41.88 | Sell |
Chaikin Money Flow: | -1994706 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.74 - 62.68) | Sell |
Bollinger Bands (100): | (44.76 - 56.7) | Buy |
OBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.06 | Buy |
20-day SMA: | 5.04 | Buy |
50-day SMA: | 5.43 | Sell |
200-day SMA: | 5.88 | Sell |
8-day EMA: | 5.25 | Buy |
20-day EMA: | 5.14 | Buy |
50-day EMA: | 5.3 | Buy |
200-day EMA: | 6 | Sell |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.68 | Sell |
20-day SMA: | 56.78 | Sell |
50-day SMA: | 54.64 | Sell |
200-day SMA: | 47.7 | Buy |
8-day EMA: | 54.12 | Sell |
20-day EMA: | 55.17 | Sell |
50-day EMA: | 54.12 | Sell |
200-day EMA: | 45.19 | Buy |
Orchestra BioMed Holdings Earnings Growth & OBIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $0.19 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.
Orchestra BioMed Holdings Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |